- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02548858
Perineorrhaphy Outcomes Related to Body Imagery (POETRY)
Perineorrhaphy Outcomes Related to Body Imagery (POETRY)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to assess the body image of women before and after pelvic reconstructive surgery with and without perineorrhaphy to examine if a perineorrhaphy impacts postoperative body image by conducting a single-blind, randomized controlled clinical trial. The central hypothesis is that patients' body image will not be affected by whether or not a perineorrhaphy is performed.
The target population are those patients with POP who are planning an apical prolapse repair. All participants will give written consent prior to their surgery. After enrollment, women will fill out baseline surveys, including the Body Image in Pelvic Organ Prolapse (BIPOP), the Pelvic organ prolapse/Incontinence Sexual Questionnaire, IUGA-revised) (PISQ-IR), the Pelvic Floor Distress Inventory (PFDI-20), and a Pain Visual Analog Scale (VAS) to assess baseline pain. Additionally, participants will undergo a Pelvic Organ Prolapse Quantification (POP-Q) examination with the addition of measurements of genital hiatus (GH) and perineal body (PB) lengths without strain. The other measurements involved in the POP-Q entail assigning numerical values to descent of different parts of the vagina. Pelvic floor muscle strength will be measured using a Peritron™ perineometer and Kegel strength (contraction of the pelvic floor muscles) using the Oxford grading scale.
On the day of the patient's surgery, the surgeon will call a research coordinator who will open the next envelope in the sequence randomizing the patient to perinorrhaphy or to no perineorrhaphy. Randomization assignment will be generated by a computer-based randomization table and assigned by a research coordinator not otherwise involved in the study. Women will not be informed to what arm of the study they were randomized, and postoperative assessments will be made by individuals not involved with the patient's surgery.
At prescribed time points post-operatively, the patients will be assessed by POP-Q, genital hiatus and perineal body measurements performed with and without strain, the pain VAS, the BIPOP, The PISQ-IR, the PFDI-20, and pelvic floor muscle strength via the Oxford scale and measurement by the Peritron™ perineometer.
The investigators' aims for this study are:
Aim #1: To determine if a patient's body image, by using the Body Image in Pelvic Organ Prolapse (BIPOP) questionnaire, is affected by concomitant performance of a perineorrhaphy at the time of pelvic organ prolapse surgery. Hypothesis: There will be no difference in body image scores between those with and without concomitant perineorrhaphy.
Aim #2: To determine if Pelvic Organ Prolapse Quantification (POP-Q) measurements are affected by a perineorrhaphy. Hypothesis: After a perineorrhaphy, the genital hiatus (GH) will be smaller, the total vaginal length (TVL) will be longer, the perineal body (PB) will be longer, and all others will be unaffected when compared to those in whom perineorrhaphy is not performed.
Aim #3: To determine if the strength of pelvic floor muscles is improved after corrective pelvic organ prolapse surgery with a perineorrhaphy compared with those patients who did not have a perineorrhaphy, as measured by the Peritron™, a perineometer device that measures pelvic floor muscle contraction strength. Hypothesis: Pelvic floor muscle strength will be unaffected by the performance of a perineorrhaphy.
Aim #4: To assess if those having a perineorrhaphy have higher postoperative pain both in the short term and long term by using a visual analog scale (VAS) both in the immediate and 6 week postoperative period. Hypothesis: Those with perineorrhaphies will report more pain on a VAS both immediately and 6 weeks post-surgery.
Aim #5: To describe if there are differences in sexual function after corrective pelvic organ prolapse with a perineorrhaphy compared to those who did not undergo a perineorrhaphy. Hypothesis: Sexual function will be improved after POP surgery repair but will be unaffected by the performance of a perineorrhaphy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- University of New Mexico
-
Rio Rancho, New Mexico, United States, 87144
- Sandoval Regional Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects ≥ 18 years of age
- Symptomatic POP who desire vaginal or abdominal apical suspension
- English-speaking/reading
- Genital hiatus measurement < 6 cm, >2cm
Exclusion Criteria:
- Those who desire colpocleisis
- Those whose surgical planning includes levatorplasty
- Genital hiatus measurements greater than or equal to 6 cm, < 2 cm
- Inability to speak/understand English
- Those who specifically request a perineorrhaphy
- Pregnant patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Perineorrhaphy
Patients who are randomized to receive a perineorrhaphy as part of their vaginal or abdominal reconstructive procedure
|
Those patients who are randomized to undergo a perineorrhaphy as part of their vaginal or abdominal reconstructive procedure for pelvic organ prolapse.
|
|
ACTIVE_COMPARATOR: No Perineorrhaphy
Patients who are randomized not to receive a perineorrhaphy as part of their vaginal or abdominal reconstructive procedure
|
Those patients who are randomized not to undergo a perineorrhaphy as part of their vaginal or abdominal reconstructive procedure for pelvic organ prolapse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Image, by using the Body Image in Pelvic Organ Prolapse (BIPOP) questionnaire
Time Frame: 6 weeks post-operatively
|
To determine if a patient's body image, by using the Body Image in Pelvic Organ Prolapse (BIPOP) questionnaire, is affected by concomitant performance of a perineorrhaphy at the time of pelvic organ prolapse surgery.
|
6 weeks post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pelvic Organ Prolapse Quantification (POP-Q) Measurements
Time Frame: Pre-operatively, in the operating room, 1 week, 6 weeks, and 3 months post-operatively
|
To determine if POP-Q measurements are affected by a perineorrhaphy, as measured immediately post-operatively, and at 1 week, 6 weeks and 3 months after surgery.
|
Pre-operatively, in the operating room, 1 week, 6 weeks, and 3 months post-operatively
|
|
Pelvic Floor Muscle Strength as measured by the Peritron™ perineometer and digitally.
Time Frame: 6 weeks post-operatively
|
To determine if the strength of pelvic floor muscles is improved after corrective pelvic organ prolapse surgery with a perineorrhaphy compared with those who did not have a perineorrhaphy, as measured by the Peritron™ perineometer and digitally.
|
6 weeks post-operatively
|
|
Post-operative Pain by using a pain visual analog scale
Time Frame: 6 weeks post-operatively
|
To assess if those having a perineorrhaphy have higher post-operative pain both in the short term and long term by using a pain visual analog scale both in the immediate and 6 week post-operative period.
|
6 weeks post-operatively
|
|
Sexual Function, as measured by the validated questionnaire, PISQ-IR
Time Frame: 3 months post-operatively
|
To describe if there are differences in sexual function after correction of pelvic organ prolapse with a perineorrhaphy compared to those that did not undergo a perineorrhaphy.
The PISQ-IR is a validated questionnaire that measures sexual function in women with pelvic floor disorders in domains such as arousal, orgasm, partner-related issues, sexual quality, desire, and takes into account those who are not sexually active.
The patients will fill out this questionnaire at a baseline visit and at post-operative visits.
|
3 months post-operatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cara S Ninivaggio, MD, University of New Mexico
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-108
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse, Patient Education | Pelvic Organ Prolapse (POP)United States
-
Hillel Yaffe Medical CenterCompletedHysterectomy | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse (POP)Israel
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Wolfson Medical CenterRecruiting
-
Queen's UniversityNot yet recruitingPelvic Organ Prolapse (POP)Canada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
Chung Shan Medical UniversityActive, not recruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Sacrocolpopexy | PectopexyTaiwan
-
A.M.I. Agency for Medical Innovations GmbHActive, not recruitingProlapse | Pelvic Organ Prolapse (POP) | SacrocolpopexyGermany
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
Clinical Trials on Perineorrhaphy
-
Lund UniversityCompletedPelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse (POP)Sweden
-
Wake Forest University Health SciencesCompletedSexual FunctionUnited States